Folitrax 2.5mg
| SKU | 666 |
|---|---|
| Generic For | Rheumatrex |
| Strength | 2.5 mg |
| Manufacturer | IPCA Laboratories |
| Active Ingredient | Methotrexate |
| Pack Size | Qty | Price Per Pill or Unit | Price | Cart | |
|---|---|---|---|---|---|
| 30 Tablet/s | US$ 0.38 | US$ 11.50 | |||
|
|||||
| 60 Tablet/s | US$ 0.30 | US$ 18.0022%US$ 23.00 | |||
|
|||||
| 90 Tablet/s | US$ 0.22 | US$ 20.0042%US$ 34.50 | |||
|
|||||
Folitrax 2.5mg – Affordable Rheumatrex Alternative for Cancer & Arthritis
Folitrax 2.5mg contains the active ingredient Methotrexate, a disease-modifying antirheumatic drug (MARD), which reduces the immune system activity of people with certain health issues. The immune system normally protects the body from infections and fights them. But in some conditions, the immune system mistakenly attacks parts of the body, such as the joints, ultimately leading to inflammation, which can bring swelling, redness, stiffness, and pain. Methotrexate reduces the body's immune system, decreases pain, swelling, and stiffness, and improves function. Doctors prescribe Methotrexate to people with various types of arthritis and relations conditions, including:
- Rheumatoid arthritis
- Reactive arthritis
- Psoriatic arthritis
- Myositis
- Vasculitis
- Enteropathic arthritis
- Systemic sclerosis
The medicine can also be given to children who are suffering with:
- Juvenile idiopathic arthritis
- Vasculitis
- Lupus
- Juvenile dermatomyositis
- Uveitis
- Localised scleroderma
Folitrax 2.5mg has been reported to cause fetal death and congenital abnormalities. Therefore, it is not recommended for women of childbearing age unless there is clear medical evidence that the benefits can be expected to outweigh the risks. Pregnant ladies with psoriasis or rheumatoid arthritis should not receive Folitrax. Because of the potential or serious side effects of Methotrexate in breastfed infants, it is contraindicated in nursing mothers. Patients with psoriasis or rheumatoid arthritis who gave evidence of immunodeficiency syndrome or had a pre-existing blood-related condition such as leukopenia, bone marrow hypoplasia, thrombocytopenia or anaemia should not receive Folitrax.
Methotrexate should not be used for a patient who has a known hypersensitivity to Methotrexate should not take this medicine. Patients should be informed of the early symptoms of toxicity, the need to see their doctor immediately if they occur, and the need for close follow-up, including laboratory tests to monitor toxicity. The recommended dose is weekly in rheumatoid arthritis and psoriasis, and the mistaken daily use of the recommended dose has led to fatal toxicity. For proper dosing, it is important to read the prescription carefully. Rarely, severe bone marrow suppression, anaemia, and gastrointestinal toxicity have been reported with concomitant administration of Methotrexate along with some non-steroidal anti-inflammatory drugs (NSAIDs). Caution should be used when NSAIDs and salicylates are administered concomitantly with lower doses of Folitrax.
Oral antibiotics such as chloramphenicol and tetracycline may decrease intestinal absorption or Methotrexate. It is generally recommended that children who are taking Methotrexate avoid live vaccines. If you are due to have surgery, ask your doctor whether it will affect your routine methotrexate treatment. Alcohol and Methotrexate affect your liver, so you mustn't drink alcohol while receiving the antirheumatic drug.
Folitrax should be taken once per week. You will be given a starting dose of Methotrexate while your doctor tries to bring your condition under control, but this may be increased if it is not helping your symptoms. Taking one strength, usually, 2.5 mg, is recommended until an adequate response is achieved. Your doctor will adjust the dose gradually to achieve optimal clinical response. Once the desired clinical response has been achieved, your doctor will reduce the dosage to the best lowest possible dosing regimen.
What is Methotrexate and what conditions does it treat?
Methotrexate is a disease-modifying antirheumatic drug (DMARD) and antimetabolite medication used to treat various autoimmune and inflammatory conditions. Folitrax 2.5mg contains methotrexate as its active ingredient and is commonly prescribed for rheumatoid arthritis, psoriasis, psoriatic arthritis, and certain types of cancer. This immunosuppressant medicine works by slowing down the body's immune response that causes joint inflammation and skin cell overgrowth. Doctors also prescribe this antirheumatic agent for severe cases of Crohn's disease and ectopic pregnancy treatment. The low-dose formulation like Folitrax 2.5mg is typically used for arthritis and skin conditions rather than cancer therapy.
How does Methotrexate work in the body?
Methotrexate functions as an antimetabolite by interfering with folic acid metabolism, which is essential for cell division and growth. Folitrax 2.5mg blocks an enzyme called dihydrofolate reductase, reducing the production of inflammatory chemicals and slowing down rapidly dividing cells. In rheumatoid arthritis treatment, this DMARD suppresses overactive immune cells that attack joint tissue, reducing swelling and preventing joint damage. For psoriasis management, the medication slows excessive skin cell reproduction that causes scaly patches. This immunomodulating action makes methotrexate effective across multiple inflammatory conditions. The therapeutic effect builds gradually as the drug accumulates and modifies disease progression over weeks.
How long does Folitrax 2.5mg take to work?
Folitrax 2.5mg typically requires four to twelve weeks before you notice significant improvement in arthritis or psoriasis symptoms. This methotrexate medication is not a fast-acting pain reliever but a disease-modifying treatment that works gradually. Some patients report reduced joint stiffness or skin inflammation within three to four weeks, though maximum therapeutic benefits usually appear after two to three months of consistent weekly dosing. Your rheumatologist may prescribe anti-inflammatory medicines or corticosteroids alongside this DMARD during the initial weeks to manage symptoms while methotrexate takes effect. Patience is essential with this immunosuppressant therapy, as stopping too early prevents the full disease-modifying benefits from developing.
When and how should I take Folitrax 2.5mg?
Folitrax 2.5mg containing methotrexate is typically taken once weekly, not daily, for arthritis and psoriasis treatment. Choose a specific day each week and take your prescribed dose at the same time to maintain consistency. Swallow the tablets whole with water, with or without food, though taking them with meals may reduce stomach upset. Many doctors prescribe folic acid supplements to take on non-methotrexate days to minimize side effects. Mark your calendar or set phone reminders since weekly dosing differs from typical daily medications. Never take this DMARD more frequently than prescribed, as methotrexate toxicity can occur with improper dosing schedules.
Is Folitrax 2.5mg safe for long-term use?
Folitrax 2.5mg can be used safely for extended periods when properly monitored by your healthcare provider. Many patients take this methotrexate formulation for years to control rheumatoid arthritis or psoriasis with regular blood tests monitoring liver function, kidney health, and blood cell counts. Long-term DMARD therapy requires ongoing medical supervision, typically with laboratory testing every eight to twelve weeks once stabilized. Most people tolerate this immunosuppressant well over time, though doctors may adjust dosages or add protective medications like folic acid. The benefits of controlling inflammatory disease progression generally outweigh risks when appropriate monitoring protocols are followed throughout extended treatment.
Can I take Folitrax 2.5mg with other medicines?
Folitrax 2.5mg containing methotrexate can interact with numerous medications, so disclosure of all medicines is essential. This DMARD should not be combined with certain antibiotics like trimethoprim, NSAIDs at high doses, or other immunosuppressants without medical guidance. Proton pump inhibitors for heartburn, some pain relievers, and certain supplements may affect how methotrexate works or increase toxicity risk. Alcohol consumption should be limited as both methotrexate and alcohol affect liver function. Many patients successfully take this antirheumatic medication alongside blood pressure drugs, diabetes medicines, and antidepressants. Always inform prescribers and pharmacists about your complete medication list before starting treatment.
How does Folitrax 2.5mg compare to similar medicines in its class?
Folitrax 2.5mg stands as one of the most established DMARDs for rheumatoid arthritis, often preferred over newer alternatives due to decades of safety data and cost-effectiveness. Compared to biologic treatments like adalimumab or etanercept, this methotrexate formulation costs significantly less while providing comparable efficacy for many patients. Other conventional DMARDs such as sulfasalazine or hydroxychloroquine may cause fewer monitoring requirements but often prove less effective for moderate to severe arthritis. Methotraxate is frequently the first-line disease-modifying treatment that rheumatologists prescribe, with biologics reserved for patients who don't respond adequately. This antirheumatic medication can also be combined with biologics for enhanced therapeutic outcomes.
Is generic Methotrexate as effective as branded versions like Folitrax?
Generic methotrexate delivers identical therapeutic effectiveness to branded formulations like Folitrax 2.5mg, as both contain the same active pharmaceutical ingredient at equivalent strengths. Regulatory authorities in the USA, UK, Australia, and Canada require generic manufacturers to prove bioequivalence, meaning the medication absorbs into your bloodstream at the same rate and extent as brand-name versions. The same disease-modifying benefits for rheumatoid arthritis and psoriasis occur regardless of whether you use generic or branded methotrexate tablets. Price differences reflect marketing and development costs rather than efficacy variations. Many patients switch between generic and branded DMARD formulations without experiencing changes in symptom control or side effects.
Why do patients choose PremiumRxDrugs for Folitrax 2.5mg?
Patients select PremiumRxDrugs for Folitrax 2.5mg for reliable access to manufacturer-sourced methotrexate at competitive prices, unavailable at many local pharmacies. As a licensed international pharmacy, we can eliminate the inconvenience of monthly pharmacy visits for chronic DMARD therapy and deliver directly to patients across the USA, UK, Australia, and Canada. The straightforward prescription management system helps arthritis and psoriasis patients maintain consistent weekly dosing schedules without medication gaps. Discreet packaging respects privacy concerns around immunosuppressant treatment, while multiple shipping options, including free delivery, reduce overall healthcare costs. Over ten years of satisfied customers demonstrate PremiumRxDrugs's commitment to authentic antirheumatic medications and dependable service for long-term disease management.
What are the common side effects of Methotrexate?
Methotrexate commonly causes nausea, mouth sores, fatigue, and stomach upset, particularly in the day or two following your weekly dose. Some people experience hair thinning, headaches, or dizziness while taking this DMARD for rheumatoid arthritis or psoriasis. Folic acid supplementation on non-methotrexate days significantly reduces these digestive and mucosal side effects for many patients. Less common reactions include increased infection susceptibility due to immunosuppression, liver enzyme elevations detected through blood tests, and temporary drops in blood cell counts. Most side effects remain mild and manageable, improving as your body adjusts to this antirheumatic medication. Severe reactions like difficulty breathing or unusual bruising require immediate medical attention.
Who should avoid taking Methotrexate?
Methotrexate is contraindicated for pregnant women or those planning pregnancy, as this medication causes severe birth defects and miscarriage. Breastfeeding mothers should not use this immunosuppressant drug. People with significant liver disease, kidney impairment, or active infections should avoid methotrexate therapy. Those with compromised immune systems, blood disorders like severe anemia, or history of alcohol abuse face increased risks with this DMARD treatment. Patients allergic to methotrexate or with stomach ulcers require alternative arthritis or psoriasis medications. Both men and women need reliable contraception during treatment and for months afterward. Your rheumatologist will assess your complete medical history before prescribing this disease-modifying antirheumatic agent.
Login
Sign Up
Login
Sign Up